Back
Fate Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
FATE
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
22
FATE
Fate Therapeutics
Last Price:
3.80
Seasonality Move:
0.56%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.Fate Therapeutics Price Quote
$3.80
Fate Therapeutics Key Stats
Sell
22
Fate Therapeutics (FATE)
is a Sell
Day range:
$3.74 - $3.95
52-week range:
$1.63 - $8.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.89
P/B ratio:
1.02%
Volume:
2.7M
Avg. volume:
2.6M
1-year change:
-34.71%
Market cap:
$377.1M
Revenue:
$63.5M
EPS:
$-1.64
How Much Does Fate Therapeutics Make?
-
How Much Are Fate Therapeutics's Sales Annually?
FATE Revenues are $63.5M -
How Much Profit Does Fate Therapeutics's Make A Year?
FATE net income is -$160.9M
Is Fate Therapeutics Growing As A Company?
-
What Is Fate Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.96% -
What Is Fate Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Fate Therapeutics Stock Price Performance
-
Did Fate Therapeutics Stock Go Up Last Month?
Fate Therapeutics share price went down by -44.61% last month -
Did FATE's Share Price Rise Over The Last Year?
FATE share price fell by -34.71% over the past 1 year
What Is Fate Therapeutics 52-Week High & Low?
-
What Is Fate Therapeutics’s 52-Week High Share Price?
Fate Therapeutics has traded as high as $8.83 over the past 52 weeks -
What Is Fate Therapeutics’s 52-Week Low Share Price?
Fate Therapeutics has traded as low as $1.63 over the past 52 weeks
Fate Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Fate Therapeutics?
-
How Much Debt Does Fate Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Fate Therapeutics Have?
Cash and short term investments quarterly total is $315.2M -
What Is Fate Therapeutics’s Book Value Per Share?
Book value per share is 3.74
Is Fate Therapeutics Cash Flow Positive?
-
What Is FATE Cash Flow From Operations?
Cash flow from operations (TTM) is -$132.3M -
What Is Fate Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $85K -
What Is Fate Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $112.7M
Fate Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FATE return on invested capital is -37.07% -
What Is Fate Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.09% -
What Is FATE Return On Equity?
ROE is a measure of profitability and is -37.07%
Fate Therapeutics Earnings Date & Stock Price
-
What Is Fate Therapeutics's Stock Price Today?
A single share of FATE can be purchased today for 3.80 -
What Is Fate Therapeutics’s Stock Symbol?
Fate Therapeutics trades on the nasdaq under the ticker symbol: FATE -
When Is Fate Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Fate Therapeutics is scheduled on May 3, 2024 -
When Is FATE's next ex-dividend date?
Fate Therapeutics's next ex-dividend date is April 30, 2020 -
How To Buy Fate Therapeutics Stock?
You can buy Fate Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Fate Therapeutics Competitors
-
Who Are Fate Therapeutics's Competitors?
Below is a list of companies who compete with Fate Therapeutics or are related in some way:
Fate Therapeutics Dividend Yield
Data Unavailable
Fate Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 9.85% |
Revenue: | -96.22% | 9.7% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 13 |
Sell Recommendations: | 0 |
Price Target: | 7.80 |
Upside from Last Price: | 105.26% |